Hyperkalemia Management and Kidney Injury Prevention

Introduction to Hyperkalemia and Kidney Function

The kidneys play a crucial role in maintaining potassium homeostasis by excreting excess potassium from the body, as stated by the American College of Physicians, based on evidence from Mayo Clinic Proceedings 1, 2
Chronic kidney disease is a significant risk factor for developing hyperkalemia due to the reduced ability to excrete potassium, according to the National Kidney Foundation, with evidence from Mayo Clinic Proceedings and other sources 1, 3, 4

Severe hyperkalemia can cause cardiac arrhythmias, hemodynamic instability, and reduced renal perfusion, leading to kidney injury, as reported by the American Heart Association, with evidence from Mayo Clinic Proceedings 1, 3
Hyperkalemia can lead to metabolic acidosis, suppression of ammoniagenesis, and worsening kidney function, as stated by the National Institute of Diabetes and Digestive and Kidney Diseases, with evidence from Mayo Clinic Proceedings 1
Patients with pre-existing chronic kidney disease, diabetes mellitus, and heart failure are at higher risk for developing hyperkalemia, according to the American Diabetes Association and the American College of Cardiology, with evidence from Mayo Clinic Proceedings and Praxis Medical Insights 1, 3

Regular monitoring of serum potassium levels is essential in high-risk patients, especially those with chronic kidney disease, heart failure, or diabetes, as recommended by the National Kidney Foundation, with evidence from Mayo Clinic Proceedings and Praxis Medical Insights 1, 3
Severe hyperkalemia requires immediate treatment with calcium, insulin, glucose, beta-agonists, or sodium bicarbonate to shift potassium into cells, as stated by the American College of Emergency Physicians, with evidence from Praxis Medical Insights 3
Discontinuing beneficial RAAS inhibitors due to mild hyperkalemia may cause more harm than benefit in patients with heart failure or chronic kidney disease, as reported by the American College of Cardiology, with evidence from Praxis Medical Insights 3

Patients with tumor lysis syndrome are at high risk for hyperkalemia due to massive release of intracellular potassium, which can precipitate acute kidney injury, as stated by the American Society of Clinical Oncology, with evidence from the Journal of Clinical Oncology 5